Nuveen Asset Management, LLC Eli Lilly & CO Transaction History

Nuveen Asset Management, LLC

$329 Billion
Q1 2024

A detailed history of Nuveen Asset Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 5,285,226 shares of LLY stock, worth $4.34 Billion. This represents 1.25% of its overall portfolio holdings.

Number of Shares

5,285,226

Previous 5,363,946 1.47%

Holding current value

$4.34 Billion

Previous $3.13 Billion 31.5%

% of portfolio

1.25%

Previous 1.03%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $46.6 Million - $62.4 Million	-78,720 Reduced 1.47%	5,285,226 $4.11 Billion
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $46.8 Million - $55.2 Million	89,168 Added 1.69%	5,363,946 $3.13 Billion
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $76 Million - $105 Million	174,753 Added 3.43%	5,274,778 $2.83 Billion
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $20.8 Million - $27.8 Million	-59,378 Reduced 1.15%	5,100,025 $2.39 Billion
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $38.3 Million - $45 Million	123,239 Added 2.45%	5,159,403 $1.77 Billion

Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $31.5 Million - $36.7 Million	-98,034 Reduced 1.91%	5,036,164 $1.84 Billion
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $13.1 Million - $14.9 Million	-44,141 Reduced 0.85%	5,134,198 $1.66 Billion
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $27.8 Million - $32.6 Million	99,705 Added 1.96%	5,178,339 $1.68 Billion
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $149 Million - $186 Million	636,694 Added 14.33%	5,078,634 $1.47 Billion
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $30.6 Million - $37.9 Million	-135,923 Reduced 2.97%	4,441,940 $1.23 Billion
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $112 Million - $138 Million	-507,035 Reduced 9.97%	4,577,863 $1.06 Billion
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $45.1 Million - $58.3 Million	-249,534 Reduced 4.68%	5,084,898 $1.17 Billion
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $197 Million - $255 Million	-1,198,133 Reduced 18.34%	5,334,432 $997 Million
Q4 2020 May 17, 2021	SELL	$130.46 - $172.63 $4.46 Million - $5.9 Million	-34,152 Reduced 0.52%	6,532,565 $1.1 Billion
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $169 Million - $224 Million	-1,296,512 Reduced 16.49%	6,566,717 $1.11 Billion
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $23.9 Million - $27.7 Million	-163,638 Reduced 2.04%	7,863,229 $1.16 Billion
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $324 Million - $389 Million	2,372,251 Added 41.95%	8,026,867 $1.32 Billion
Q1 2020 May 14, 2020	BUY	$119.05 - $147.35 $183 Million - $226 Million	1,533,024 Added 37.19%	5,654,616 $784 Million
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $293 Million - $363 Million	-2,740,499 Reduced 39.94%	4,121,592 $542 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $43.1 Million - $46.9 Million	-403,753 Reduced 5.56%	6,862,091 $767 Million
Q2 2019 Aug 15, 2019	BUY	$110.79 - $129.32 $801 Million - $935 Million	7,229,751 Added 20030.9%	7,265,844 $805 Million
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $35,730 - $42,057	-321 Reduced 0.88%	36,093 $4.68 Million
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $31,134 - $34,880	-294 Reduced 0.8%	36,414 $4.21 Million
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $61,733 - $77,155	-719 Reduced 1.92%	36,708 $3.94 Million
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $21,574 - $24,760	285 Added 0.77%	37,427 $3.19 Million
Q1 2018 May 14, 2018	SELL	$74.21 - $87.6 $1,038 - $1,226	-14 Reduced 0.04%	37,142 $2.87 Million
Q4 2017 Feb 14, 2018	SELL	$81.94 - $87.89 $26,958 - $28,915	-329 Reduced 0.88%	37,156 $0
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $2.89 Million - $3.21 Million	37,485	37,485 $3.21 Million

Others Institutions Holding LLY

# of Institutions

3,712

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $779B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Eli Lilly & CO Transaction History